Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies

被引:40
|
作者
Lin, Richard J. [1 ]
Elko, Theresa A. [1 ]
Devlin, Sean M. [2 ]
Shahrokni, Armin [3 ,4 ]
Jakubowski, Ann A. [1 ,4 ]
Dahi, Parastoo B. [1 ,4 ]
Perales, Miguel-Angel [1 ,4 ]
Tamari, Roni [1 ,4 ]
Shaffer, Brian C. [1 ,4 ]
Sauter, Craig S. [1 ,4 ]
Papadopoulos, Esperanza B. [1 ,4 ]
Gyurkocza, Boglarka [1 ,4 ]
Korc-Grodzicki, Beatriz [3 ,4 ]
Barker, Juliet N. [1 ,4 ]
Maloy, Molly A. [1 ]
Giralt, Sergio A. [1 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Adult BMT Serv, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Geriatr Serv, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
ACUTE MYELOID-LEUKEMIA; COMORBIDITY INDEX; RISK-ASSESSMENT; SURVIVAL; AGE; VALIDATION; FERRITIN; ALBUMIN;
D O I
10.1038/s41409-019-0654-6
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Older patients are at increased risk for complications and death following allogeneic hematopoietic cell transplantation (allo-HCT). Traditional transplant-specific prognostic indices such as hematopoietic cell transplant comorbidity index (HCT-CI) may not capture all underlying geriatric vulnerabilities, and in-depth evaluation by a geriatrician prior to transplant may not always be available. We hypothesize that routine pretransplant interdisciplinary clinical assessment may uncover prognostically important geriatric deficits. Using an institutional database of 457 adults aged 60 years and older who underwent first allo-HCT for hematological malignancies from 2010 to 2017, we examined the prognostic impact of pretransplant deficits in geriatric domains of function, mobility, mood, medication, nutrition, and relevant biochemical markers. We found that impairment in instrumental activities of daily living (IADL) was associated with reduced survival through increased nonrelapse mortality (NRM, HR=1.82; 95% CI, 1.04-3.19). The combination of IADL impairment with either HCT-CI/age index or disease risk index readily stratified NRM and overall survival, respectively. In addition, we found that even mild renal dysfunction adversely impacted survival in older transplant patients. Our findings establish important geriatric vulnerabilities in older patients prior to allo-HCT and may provide an entry point for prospective, interventional trials to improve their outcomes.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [11] Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation
    Shah, Nirali N.
    Borowitz, Michael J.
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather J.
    Loeb, David
    Wayne, Alan S.
    Chen, Allen R.
    BLOOD, 2012, 120 (21)
  • [12] Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies
    Cox, Emily R.
    Summers, Corinne
    Milano, Filippo
    Dahlberg, Ann
    Bleakley, Marie
    Sandmaier, Brenda M.
    Thakar, Monica S.
    ANNALS OF HEMATOLOGY, 2024, 103 (09) : 3737 - 3743
  • [13] The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients
    Lin, Richard J.
    Michaud, Laure
    Lobaugh, Stephanie M.
    Nakajima, Reiko
    Mauguen, Audrey
    Elko, Theresa A.
    Ruiz, Josel D.
    Maloy, Molly A.
    Sauter, Craig S.
    Dahi, Parastoo B.
    Perales, Miguel-Angel
    Shah, Gunjan L.
    Castillo Flores, Nerea
    Sanchez-Escamilla, Miriam
    Tomas, Ana Alarcon
    San Segundo, Lucrecia Yanez
    Cho, Christina
    Politikos, Ioannis
    Kim, Soo Jung
    Korc-Grodzicki, Beatriz
    Devlin, Sean M.
    Scordo, Michael
    Schoder, Heiko
    Giralt, Sergio A.
    Hamlin, Paul A.
    LEUKEMIA & LYMPHOMA, 2020, 61 (08) : 1833 - 1841
  • [14] Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
    Sorror, Mohamed L.
    Sandmaier, Brenda M.
    Storer, Barry E.
    Franke, Georg N.
    Laport, Ginna G.
    Chauncey, Thomas R.
    Agura, Edward
    Maziarz, Richard T.
    Langston, Amelia
    Hari, Parameswaran
    Pulsipher, Michael A.
    Bethge, Wolfgang
    Sahebi, Firoozeh
    Bruno, Benedetto
    Maris, Michael B.
    Yeager, Andrew
    Petersen, Finn Bo
    Vindelov, Lars
    McSweeney, Peter A.
    Huebel, Kai
    Mielcarek, Marco
    Georges, George E.
    Niederwieser, Dietger
    Blume, Karl G.
    Maloney, David G.
    Storb, Rainer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (17): : 1874 - 1883
  • [15] Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Older Adults: Geriatric Principles in the Transplant Clinic
    Wildes, Tanya M.
    Stirewalt, Derek L.
    Medeiros, Bruno
    Hurria, Arti
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (01): : 128 - 136
  • [16] Impact of muscle loss in children with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation
    Suzuki, Daisuke
    Kobayashi, Ryoji
    Yamamoto, Masaki
    Matsushima, Satoru
    Hori, Daiki
    Yanagi, Masato
    Kodama, Koya
    Sano, Hirozumi
    Akane, Yusuke
    Igarashi, Keita
    Kobayashi, Kunihiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (01) : 128 - 133
  • [17] Impact of muscle loss in children with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation
    Daisuke Suzuki
    Ryoji Kobayashi
    Masaki Yamamoto
    Satoru Matsushima
    Daiki Hori
    Masato Yanagi
    Koya Kodama
    Hirozumi Sano
    Yusuke Akane
    Keita Igarashi
    Kunihiko Kobayashi
    International Journal of Hematology, 2023, 117 : 128 - 133
  • [18] Functional Status Is Associated with Outcomes after Allogeneic Stem Cell Transplantation for Older Patients with Hematologic Malignancies
    Huang, Li-Wen
    Huang, Chiung-Yu
    Andreadis, Charalambos
    Logan, Aaron C.
    Mannis, Gabriel N.
    Smith, Catherine C.
    Gaensler, Karin M.
    Martin, Thomas G., III
    Damon, Lloyd E.
    Steinman, Michael A.
    Olin, Rebecca L.
    BLOOD, 2018, 132
  • [19] Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation
    Mielcarek, Marco
    Storer, Barry E.
    Flowers, Mary E. D.
    Storb, Rainer
    Sandmaier, Brenda M.
    Martin, Paul J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (10) : 1160 - 1168
  • [20] Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies
    Gürman, G
    Arat, M
    Ilhan, O
    Konuk, N
    Beksaç, M
    Çelebi, H
    Özcan, M
    Arslan, Ö
    Üstün, C
    Akan, H
    Uysal, A
    Koç, H
    CYTOTHERAPY, 2001, 3 (04) : 253 - 260